- US12616740utility2026Methods of Using a GIP/GLP1 Co-agonist for Therapy0 cites4.5 ★
- US12617851utility2026TREM2 Antibodies and Uses Thereof0 cites4.5 ★
- US12611508utility2026Medication Delivery Device with Needle Carrier0 cites
- US12600733utility2026KRAS Inhibitors0 cites
- US12600767utility2026Compounds and Methods Targeting Epiregulin0 cites
- USD1121811design2026Pharmaceutical Tablet0 cites
- USD1121723design2026Label0 cites
- USD1121136design2026Pharmaceutical Tablet0 cites
- US12589134utility2026Compositions and Methods of Use of Interleukin-10 in Combination with Immune Check-point Pathway Inhibitors0 cites
- US12590064utility2026Substituted Benzamides for Inhibiting Perk Activity0 cites
- US12590105utility2026Kras G12C Inhibitors0 cites
- USD1120290design2026Pharmaceutical Tablet0 cites
- US12582779utility2026Medication Delivery Device with Rotation Sensor0 cites
- US12577229utility2026Substituted {5-methoxy-6-[(5-methoxypyridin-2-yl)methoxy]pyridin-3-yl} Methyl Compounds as CSF-1R Inhibitors0 cites
- US12581586utility2026Systems and Methods for Igniting Plasma Within Tubes0 cites
- US12569616utility2026Multi-use Drug-delivery Device0 cites
- US12564687utility2026Devices and Processes for Delivery of Therapeutic Fluids0 cites
- US12559550utility2026Crystallization of Antibodies or Antigen-binding Fragments0 cites
- US12558345utility2026CHK1/2 Inhibitors for Use in the Treatment of Neuroblastomas And/or Soft Tissue Sarcomas0 cites
- US12558430utility2026Dual Amylin and Calcitonin Receptor Agonists and Uses Thereof0 cites
Page 1 of 11Next →